The Icahn School of Medicine at Mt. Sinai is requesting funds for the purchase of a Helios Mass Cytometer, manufactured by Fluidigm Inc., to facilitate basic, translation and clinical research discovery. Mass cytometry is a cutting edge technology that merges the high-throughput single cell analysis of flow cytometry with the specificity and resolution of mass spectrometry; antibodies conjugated to purified rare-earth metal isotopes are used to label complex mixtures of cells, which are then analyzed by time-of-flight mass spectrometry. By overcoming the limitations of fluorescent spectral emission, this allows over forty parameters (with the potential for over 100 with future reagent development) to be simultaneously measured on a single cell basis, thereby allowing deeper phenotypic and functional profiling of heterogeneous cell samples to yield mechanistic insights into biological processes and novel biomarkers of disease progression and responses to therapy. While mass cytometry offers tremendous potential for scientific discovery, some of the major challenges in successfully establishing this technology include the need for specialized infrastructure, technical and scientific expertise, reagents and protocols, and computational resources. Mt. Sinai acquired a second-generation CyTOF2 mass cytometry in 2013 and has already successfully overcome all these challenges to establish a highly-productive full-service mass cytometry program as part of the Human Immune Monitoring Core, which is currently utilized by over 50 NIH-funded investigators. The impetus for this application is that our current instrumentation is utilized at capacity, and we require a second instrument to meet the growing mass cytometry needs of our scientific and clinical community. By having already heavily invested in the necessary infrastructure and reagents, and established deep scientific, technical, computational expertise related to mass cytometry, we can assure the smooth and successful integration of a Helios mass cytometer and maximize its impact on Mt. Sinai's translational and clinical research efforts.

Public Health Relevance

The Icahn School of Medicine at Mt. Sinai is requesting funds for a Helios Mass Cytometer to expand the capabilities an existing heavily-utilized mass cytometry program. Mt Sinai has already heavily invested in the necessary infrastructure, expertise and reagents to successfully leverage the capabilities of this technology to allow in-depth cellular characterization for basic, translational and clinical discovery in a wide range of disease area including cancer, immunology, allergy, virology, inflammatory bowel disease, diabetes and cardiovascular disease. The new Helios Cytometer would allow an expansion of the mass cytometry program to meet the demands of the scientific and clinical research community.

National Institute of Health (NIH)
Office of The Director, National Institutes of Health (OD)
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-CB-A (30)I)
Program Officer
Horska, Alena
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Wroblewska, Aleksandra; Dhainaut, Maxime; Ben-Zvi, Benjamin et al. (2018) Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens. Cell 175:1141-1155.e16
Linde, Nina; Casanova-Acebes, Maria; Sosa, Maria Soledad et al. (2018) Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun 9:21
Kuo, Pei-Yu; Jatiani, Shashidhar S; Rahman, Adeeb H et al. (2018) SOX11 augments BCR signaling to drive MCL-like tumor development. Blood 131:2247-2255
Williams, Jesse W; Giannarelli, Chiara; Rahman, Adeeb et al. (2018) Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease: JACC Macrophage in CVD Series (Part 1). J Am Coll Cardiol 72:2166-2180
Uzzan, Mathieu; Tokuyama, Minami; Rosenstein, Adam K et al. (2018) Anti-?4?7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. Sci Transl Med 10:
Amir, El-Ad David; Guo, Xinzheng V; Mayovska, Oksana et al. (2018) Average Overlap Frequency: A simple metric to evaluate staining quality and community identification in high dimensional mass cytometry experiments. J Immunol Methods 453:20-29